COVID-19 CLINICAL TRIAL SITES

Refer to this map to locate a clinical trial site near you that is currently participating in Humanigen's Phase 3 study of lenzilumab™ in patients with COVID-19.

For more information regarding this trial, visit StopStorm.com, visit ClinicalTrials.gov (Identifier: NCT04351152)or contact:

 

CTI Clinical Trial & Consulting Services (CRO)

1-800-732-4126

HumanigenPhase3@ctifacts.com

  • Twitter

©2020 Humanigen, Inc.  All rights reserved